Renalytix plc (RNLXY): Depreciation & Amortization
Not updated since 2024-06-30. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$364.0K
Year ended 2024-06-30
+8.9%
3-year compound annual growth
+63.7%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2024-06-30 | $364.0K | -28.3% | 2024-09-30, From 2023-07-01 |
| 2023-06-30 | $508.0K | +3.9% | 2024-09-30, From 2022-07-01 |
| 2022-06-30 | $489.0K | +73.4% | 2023-09-28, From 2021-07-01 |
| 2021-06-30 | $282.0K | +302.9% | 2022-10-31, From 2020-07-01 |
| 2020-06-30 | $70.0K | +125.8% | 2022-10-31, From 2019-07-01 |
| 2019-06-30 | $31.0K | n/a | 2022-08-01, From 2018-07-01 |